Lukatch Heath
Director
2 companies
Insider Signal Score
41
WeakTrades Analyzed
8
12M Win Rate
0.0%
Avg 3M Return
+1.0%
Avg 12M Return
-28.9%
Lukatch Heath serves as a Director at PCVX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 37 sells. Those positions are worth an estimated $1.1M at current prices.
Historically, Lukatch Heath's trades have earned a below-average insider score of 41/100 across 8 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -28.9%.
The biggest single holding is PCVX (~$998K) as Director. The recent filings there lean toward selling, a net 34,000 shares.
Holdings by Company
Transaction History
Showing 10 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2024 | PCVX Vaxcyte, Inc. | Director | Sale+OE | 5,000 | $71.50 | $357,500.00 | -47.1% | -15.2% | +28.7% | |
| Jan 29, 2024 | PCVX Vaxcyte, Inc. | Director | Sale+OE | 4,000 | $67.50 | $270,000.00 | -41.6% | -10.9% | +34.5% | |
| Jan 2, 2024 | PCVX Vaxcyte, Inc. | Director | Sale+OE | 13,000 | $63.76 | $828,915.03 | -24.9% | +6.0% | +32.3% | |
| Jan 10, 2023 | PCVX Vaxcyte, Inc. | Director | Sale+OE | 315 | $46.12 | $14,526.47 | -4.7% | -21.2% | +34.1% | |
| Dec 12, 2022 | PCVX Vaxcyte, Inc. | Director | Sale+OE | 335 | $43.93 | $14,717.13 | -4.9% | -14.5% | +29.7% | |
| Nov 10, 2022 | PCVX Vaxcyte, Inc. | Director | Sale+OE | 4,335 | $46.13 | $199,988.57 | -29.7% | +0.9% | +7.5% | |
| Oct 26, 2022 | PCVX Vaxcyte, Inc. | Director | Sale+OE | 7,015 | $36.90 | $258,856.65 | -52.9% | +10.6% | +18.3% | |
| Aug 15, 2019 | INGN Inogen Inc | Director | Buy | 2,000 | $43.01 | $86,020.00 | +57.5% | - | - | |
| Nov 6, 2018 | INGN Inogen Inc | Director | Sale+OE | 500 | $193.97 | $96,987.00 | -13.3% | - | - | |
| Oct 5, 2018 | INGN Inogen Inc | Director | Sale+OE | 500 | $218.23 | $109,114.50 | -6.4% | - | - |
Page 1Next →